leadforensics

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

PHARMA REPORT

rss_Pharma.jpg...see all
World Marine Derived Drugs Market Forecast 2017-2027

World Marine Derived Drugs Market Forecast 2017-2027

Prospects by Drug Type (Phenol, Steroid, Ether, Peptide, Other), Source (Algae, Invertebrate, Microorganism), Application (Anti-Microbial, Anti-Tumour, Cardiovascular, Anti-Viral, Anti-Inflammatory), and Geography

Product code: PHA0242

  • Publication date: 25/09/2017
  • Number of Pages: 172
  1. Report Details
  2. Table of Contents
  3. Companies Listed

Report Details

Marine Derived Drugs – our new study reveals trends, R&D progress, and predicted revenues
Where is the Marine Derived Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 172-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Marine Derived Drugs market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level.

Global Marine-Derived Drugs Market by Type
• Steroid
• Ether
• Peptide
• Other

Global Marine-Derived Drugs Market by Source
• Algae
• Invertebrates
• Microorganisms

Global Marine-Derived Drugs Market by Application
• Anti-microbial
• Anti-tumour
• Anti-cardiovascular
• Anti-viral
• Anti-inflammatory
• Other

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:

• North America:
• US
• Canada
• Mexico

• South America:
• Brazil
• Argentina
• Paraguay
• Bolivia
• Rest of South America

World Marine Derived Drugs Market Forecast 2017-2027

• Europe:
• Germany
• The UK
• Italy
• Spain
• France
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia
• Thailand
• Rest of Asia-Pacific

• Rest of the World:
• Middle East
• Africa
• Other Countries

The report also includes profiles and for some of the leading companies in the Marine Derived Drugs market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Australia in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Marine Derived Drugs will surpass $9.3bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Marine Derived Drugs Market report helps you
In summary, our 172-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 7 regional and 17 key national markets – See forecasts for the marine-derived drugs market in North America, South America, Europe, Asia-Pacific, the Middle East, Africa and Other Countries. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Bolivia, Paraguay, Germany, France, the UK, Italy, Spain, China, India, Japan, Australia and Thailand
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Marine Derived Drugs market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Marine Derived Drugs market and leading companies. You will find data, trends and predictions.

Get our report today World Marine Derived Drugs Market Forecast 2017-2027: Prospects by Drug Type (Phenol, Steroid, Ether, Peptide, Other), Source (Algae, Invertebrate, Microorganism), Application (Anti-Microbial, Anti-Tumour, Cardiovascular, Anti-Viral, Anti-Inflammatory), and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Table of Contents

1. Report Overview
1.1 Marine Derived Drugs Overview
1.2 Research Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Evaluation & Forecasting Methodology
1.3 Global Marine-Derived Drugs Market Segmentation
1.4 Overview of Findings
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Frequently Asked Questions (FAQ)
1.9 Who is This Report For?
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction to the Marine-Derived Drugs Market

3. Global Marine-Derived Drugs Market Forecast to 2027
3.1 Marine-Derived Drugs Market by Type
3.2 Marine-Derived Drugs Market by Source
3.3 Marine-Derived Drugs Market by Application

4. Marine-Derived Drugs Market by Type: Market Forecast to 2027
4.1 Overview
4.2 Marine-Derived Phenol Drugs: Market Forecast to 2027
4.3 Marine-Derived Steroid Drugs: Market Forecast to 2027
4.4 Marine-Derived Ether Drugs: Market Forecast to 2027
4.5 Marine-Derived Peptide Drugs: Market Forecast to 2027
4.6 Other Marine-Derived Drugs: Market Forecast to 2027

5. Marine-Derived Drugs Market by Source: Market Forecast, 2017-2027
5.1 Overview
5.2 Algae-Derived Drugs Market: Market Forecast, 2017-2027
5.3 Invertebrate-Derived Drugs Market: Market Forecast, 2017-2027
5.4 Marine Microorganism-Derived Drugs Market: Market Forecast, 2017-2027

6. Marine-Derived Drugs Market by Application: Market Forecast, 2017-2027
6.1 Marine-Derived Anti-Microbial Drugs: Market Forecast to 2027
6.2 Marine-Derived Anti-Tumour Drugs: Market Forecast to 2027
6.3 Marine-Derived Cardiovascular Drugs: Market Forecast to 2027
6.4 Marine-Derived Anti-Viral Drugs: Market Forecast to 2027
6.5 Marine-Derived Anti-Inflammatory Drugs: Market Forecast to 2027

7. Leading National Markets, 2017-2027
7.1 Geographical Breakdown of the Global Marine-Derived Drugs Market
7.2 North America Marine-Derived Drugs Market Forecast, 2017-2027
7.2.1 USA Marine-Derived Drugs Market Forecast, 2017-2027
7.2.2 Canada Marine-Derived Drugs Market Forecast, 2017-2027
7.2.3 Mexico Marine-Derived Drugs Market Forecast, 2017-2027
7.3 South America Marine-Derived Drugs Market Forecast, 2017-2027
7.3.1 Brazil Marine-Derived Drugs Market Forecast, 2017-2027
7.3.2 Argentina Marine-Derived Drugs Market Forecast, 2017-2027
7.3.3 Paraguay Marine-Derived Drugs Market Forecast, 2017-2027
7.3.4 Bolivia Marine-Derived Drugs Market Forecast, 2017-2027
7.3.5 Rest of South America Marine-Derived Drugs Market Forecast, 2017-2027
7.4 European Marine-Derived Drugs Market Forecast, 2017-2027
7.4.1 Germany Marine-Derived Drugs Market Forecast, 2017-2027
7.4.2 France Marine-Derived Drugs Market Forecast, 2017-2027
7.4.3 UK Marine-Derived Drugs Market Forecast, 2017-2027
7.4.4 Spain Marine-Derived Drugs Market Forecast, 2017-2027
7.4.5 Italy Marine-Derived Drugs Market Forecast, 2017-2027
7.4.6 Rest of Europe Marine-Derived Drugs Market Forecast, 2017-2027
7.5 Asia-Pacific Marine-Derived Drugs Market Forecast, 2016-2027
7.5.1 China Marine-Derived Drugs Market Forecast, 2017-2027
7.5.2 Japan Marine-Derived Drugs Market Forecast, 2017-2027
7.5.3 India Marine-Derived Drugs Market Forecast, 2017-2027
7.5.4 Australia Marine-Derived Drugs Market Forecast, 2017-2027
7.5.5 Thailand Marine-Derived Drugs Market Forecast, 2017-2027
7.5.6 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast, 2017-2027
7.6 Rest of World Marine-Derived Drugs Market Forecast, 2017-2027
7.6.1 Middle East Marine-Derived Drugs Market Forecast, 2017-2027
7.6.2 Africa Marine-Derived Drugs Market Forecast, 2017-2027
7.6.3 Other Countries Marine-Derived Drugs Market Forecast, 2017-2027

8. Marine-Derived Drugs Market, Qualitative Analysis, 2017-2027
8.1 Porter’s Five Forces Analysis of the Marine-Derived Drugs Market 2017-2027
8.1.1 Bargaining Power of Buyers (High)
8.1.2 Bargaining Power of Suppliers (Medium)
8.1.3 Threat of New Entrants (Low)
8.1.4 Threat of Substitute Products (Low)
8.1.5 Intensity of Competitive Rivalry (High)
8.2 Drivers & Restrains
8.2.1 Rising Incidence and Prevalence of Various Cancer Types
8.2.2 Increasing Investment from Government, Public and Private Sector
8.2.3 Increasing Clinical Trials
8.2.4 Increasing Popularity of Marine Derived Drugs
8.2.5 Strong Growth in Emerging Markets
8.2.6 New Healthcare Technologies May Enable Marine Derived Drugs Approvals
8.2.7 Large pool of geriatric population and related rise in chronic diseases

9. Leading Companies in Marine-Derived Drugs Market
9.1 Abbott Laboratories Inc.
9.1.1 Abbott Laboratories Inc.: Company Overview
9.1.2 Abbott Laboratories Inc.: Product Portfolio
9.2 GlaxoSmithKline PLC
9.2.1 GlaxoSmithKline PLC: Company Overview
9.2.2 GlaxoSmithKline PLC: Product Portfolio
9.3 Abbvie Inc.
9.3.1 Abbvie Inc.: Company Overview
9.3.2 Abbvie Inc.: Product Portfolio
9.4 Pharma Marine AS
9.4.1 Pharma Marine: Company Overview
9.4.2 Pharma Marine: Product Portfolio
9.5 Takeda Pharmaceutical Company Ltd. (Takeda Oncology’s Millennium)
9.5.1 Takeda Pharmaceutical Company Ltd.: Company Overview
9.5.2 Takeda Pharmaceutical Company Ltd.: Product Portfolio
9.5.3 Takeda Pharmaceutical Company Ltd.: Recent Developments
9.6 Aker BioMarine AS
9.6.1 Aker BioMarine AS: Company Overview
9.6.2 Aker BioMarine AS: Recent Developments
9.7 Marine Polymer Technologies, Inc.
9.7.1 Marine Polymer Technologies, Inc.: Company Overview
9.8 Sea Run Holdings, Inc.
9.8.1 Sea Run Holdings, Inc.: Company Overview
9.8.2 Sea Run Holdings, Inc.: Product Portfolio
9.9 Aphios Corporation
9.9.1 Aphios Corporation: Company Overview
9.9.2 Aphios Corporation: Product Portfolio
9.10 Sanofi S.A. (Sanofi Genzyme)
9.10.1 Sanofi S.A.: Company Overview
9.10.2 Sanofi S.A.: Product Portfolio
9.11 Other Companies of Interest in the Marine Derived Drugs Market

10. Conclusions
10.1 Current Leading Segments
10.2 Leading Regional Markets
10.3 Emerging Markets
10.4 The Future of the Market?

11. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

List of Figures
Figure 3.1 Marine-Derived Drugs Market, by Type, ($m), 2017-2027
Figure 3.2 Marine-Derived Drugs Market, by Source, ($m), 2017-2027
Figure 3.3 Marine-Derived Drugs Market, by Application, ($m), 2017-2027
Figure 4.1 Marine-Derived Drugs Market, by Type (%), 2016
Figure 4.2 Marine-Derived Drugs Market, by Type, Forecast ($m) 2017-2027
Figure 4.3 Global Marine-Derived Phenol Drugs Market Forecast, by Geography, ($m) 2017-2027
Figure 4.4 Global Marine-Derived Steroid Drugs Drugs Market Forecast, by Geography, ($m) 2017-2027
Figure 4.5 Global Marine-Derived Ether Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Figure 4.6 Global Marine-Derived Peptide Drugs Market Forecast, by Geography, ($m) 2017-2027
Figure 4.7 Global Other Marine-Derived Drugs Market Forecast, by Geography, ($m) 2017-2027
Figure 5.1 Marine-Derived Drugs Market, by Source, ($m) 2017-2027
Figure 5.2 Marine-Derived Drugs Market, by Source, Market Share (%), 2016
Figure 5.3 Algae-Derived Drugs Market Forecast, by Geography ($m) 2017-2027
Figure 5.4 Invertebrate-Derived Drugs Market Forecast, by Geography($m) 2017-2027
Figure 5.5 Marine Microorganism-Derived Drugs Market, by Geography($m) 2017-2027
Figure 6.1 Marine-Derived Drugs Market Forecast, by Application, ($million) 2017-2027
Figure 6.2 Marine-Derived Drugs Market, by Application, Market Share (%), 2016
Figure 6.3 Marine-Derived Drugs Market Forecast for Anti-microbial, by Geography, ($m) 2017-2027
Figure 6.4 Marine-Derived Drugs Market Forecast for Anti-tumour, by Geography, ($m) 2017-2027
Figure 6.5 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, by Geography, ($m) 2017-2027
Figure 6.6 Marine-Derived Drugs Market Forecast for Anti-viral, by Geography, ($m) 2017-2027
Figure 6.7 Marine-Derived Drugs Market Forecast for Anti-Inflammatory, by Geography, ($m) 2017-2027
Figure 6.8 Marine-Derived Drugs Market Forecast for Other Indications, by Geography ($m) 2017-2027
Figure 7.1 Global Marine-Derived Drugs Market Forecast, by Geography($m) 2017-2027
Figure 7.2 Global Marine-Derived Drugs Market Forecast, by Geography, Market Share (%), 2016
Figure 7.3 North America Marine-Derived Drugs Market Forecast, by Country, ($m), 2017-2027
Figure 7.4 North America Marine-Derived Drugs Market Forecast, by Geography, Market Share (%), 2016
Figure 7.5 USA Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.6 Canada Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.7 Mexico Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.8 South America Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027
Figure 7.9 South America Marine-Derived Drugs Market, by Country, Market Share (%), 2016
Figure 7.10 Brazil Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.11 Argentina Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.12 Paraguay Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.13 Bolivia Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.14 Rest of South America Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.15 Europe Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027
Figure 7.16 Europe Marine-Derived Drugs Market, by Country, Market Share (%), 2016
Figure 7.17 Germany Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.18 France Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.19 UK Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.20 Spain Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.21 Italy Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.22 Rest of Europe Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.23 Asia-Pacific Marine-Derived Drugs Market Forecast, by Country($million) 2017-2027
Figure 7.24 Asia-Pacific Marine-Derived Drugs Market, Market Share (%), 2016
Figure 7.25 China Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.26 Japan Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.27 India Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.28 Australia Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.29 Thailand Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.30 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.31 RoW Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027
Figure 7.32 Rest of World Marine-Derived Drugs Market, by Country, Market Share (%), 2016
Figure 7.33 Middle East Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.34 Africa Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 7.35 Other Countries Marine-Derived Drugs Market Forecast ($m) 2017-2027
Figure 8.1 Porter’s Five Forces Analysis of the Marine-Derived Drugs Market
Figure 9.1 Abbott Laboratories Inc., Revenue, ($million), 2012-2016
Figure 9.2 Abbott Laboratories Inc., Geographic Presence Share (%), 2016
Figure 9.3 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
Figure 9.4 GlaxoSmithKline PLC, Product Segments Share (%), 2016
Figure 9.5 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
Figure 9.6 Abbvie Inc., Revenue, ($million), 2012-2016
Figure 9.7 Abbvie Inc.,Product Segments Share (%), 2016
Figure 9.8 Abbvie Inc., Geographical Presence Share (%), 2016
Figure 9.9 Takeda Pharmaceutical Company Ltd., Revenue, ($million), 2012-2016
Figure 9.10 Aker BioMarine AS, Revenue, ($million), 2012-2016
Figure 9.11 Aker BioMarine AS., Geographical Presence Share (%), 2016
Figure 9.12 Sanofi S.A., Revenue, ($million), 2012-2016
Figure 9.13 Sanofi S.A., Product Segments Share (%), 2016
Figure 9.14 Sanofi S.A., Geographical Presence Share (%), 2016
Figure 10.1 World Marine-Derived Drugs, by Type, ($million), 2017-2027
Figure 10.2 World Marine-Derived Drugs, by Sources, ($million), 2017-2027
Figure 10.3 World Marine-Derived Drugs, by End-User, ($million), 2017-2027
Figure 10.4 World Marine-Derived Drugs, by Geography, ($million), 2017-2027

List of Tables
Table 3.1. Marine-Derived Drugs Market Forecast ($m, AGR%) 2017-2027
Table 4.1. Marine-Derived Drugs Market Forecast, by Type ($m, AGR%) 2017-2027
Table 4.2 Global Marine-Derived Phenol Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 4.3 Marine-Derived Phenol Drugs Market Forecast, by Geography, ($m, AGR%) 2017-2027
Table 4.4 Global Marine-Derived Steroid Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 4.5 Global Marine-Derived Steroid Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Table 4.6 Global Marine-Derived Ether Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 4.7 Global Marine-Derived Ether Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Table 4.8 Global Marine-Derived Peptide Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 4.9 Global Marine-Derived Peptide Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Table 4.10 Global Other Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 4.11 Global Other Marine-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Table 5.1 Marine-Derived Drugs Market, by Source ($m, AGR%) 2017-2027
Table 5.2 Algae-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 5.3 Algae-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Table 5.4 Invertebrate-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 5.5 Invertebrate-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
Table 5.6 Marine Microorganism-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 5.7 Marine Microorganism-Derived Drugs Market, by Geography ($m, AGR%) 2017-2027
Table 6.1 Marine-Derived Drugs Market, by Application($m, AGR%) 2017-2027
Table 6.2 Marine-Derived Drugs Market Forecast for Anti-Microbial Applications ($m, AGR%) 2017-2027
Table 6.3 Marine-Derived Drugs Market Forecast for Anti-microbial, by Geography ($m, AGR%), 2017-2027
Table 6.4 Marine-Derived Drugs Market Forecast for Anti-Microbial ($m, AGR%) 2017-2027
Table 6.5 Marine-Derived Drugs Market Forecast for Anti-tumour, by Geography ($m, AGR%) 2017-2027
Table 6.6 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, ($m, AGR%) 2017-2027,
Table 6.7 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, by Geography ($m, AGR%) 2017-2027
Table 6.8 Marine-Derived Drugs Market Forecast for Anti-viral ($m, AGR%) 2017-2027
Table 6.9 Marine-Derived Drugs Market Forecast for Anti-viral, by Geography ($m, AGR%) 2017-2027
Table 6.10 Marine-Derived Drugs Market Forecast for Anti- inflammatory ($m, AGR%) 2017-2027
Table 6.11 Marine-Derived Drugs Market Forecast for Anti-Inflammatory, by Geography ($m. AGR%) 2017-2027
Table 6.12 Marine-Derived Drugs Market for Other Indications, ($m, AGR%) 2017-2027
Table 6.13 Marine-Derived Drugs Market Forecast for Other Indications, by Geography ($m, AGR%) 2017-2027
Table 7.1 Marine-Derived Drugs Market Forecast by Geography ($m, AGR%) 2017-2027
Table 7.2 North America Marine-Derived Drugs Market Forecast, by Country, ($m, AGR%), 2017-2027
Table 7.3 USA Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.4 Canada Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.5 Mexico Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.6 South America Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
Table 7.7 Brazil Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.8 Argentina Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.9 Paraguay Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.10 Bolivia Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.11 Rest of South America Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.12 European Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
Table 7.13 Germany Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.14 France Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.15 UK Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.16 Spain Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.17 Italy Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.18 Rest of European Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.19 Asia-Pacific Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
Table 7.20 China Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.21 Japan Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.22 India Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.23 Australia Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.24 Thailand Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.25 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.26 Rest of World Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
Table 7.27 Middle East Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.28 Africa Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 7.29 Other Countries Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
Table 8.2 Worldwide Estimated Incidence and Prevalence of all Cancer Types, (2012)
Table 9.1 Abbott Laboratories Inc.: Company Overview
Table 9.2 Abbott Laboratories Inc.: Product Portfolio
Table 9.3 GlaxoSmithKline PLC: Company Overview
Table 9.4 GlaxoSmithKline PLC: Product Portfolio
Table 9.5 Abbvie Inc.: Company Overview
Table 9.6 Abbvie Inc.: Product Portfolio
Table 9.7 Pharma Marine: Company Overview
Table 9.8 Pharma Marine: Product Portfolio
Table 9.9 Takeda Pharmaceutical Company Ltd.: Company Overview
Table 9.10 Takeda Pharmaceutical Company Ltd.: Product Portfolio
Table 9.11 Takeda Pharmaceutical Company Ltd.: Recent Developments
Table 9.12 Aker BioMarine AS: Company Overview
Table 9.13 Aker BioMarine AS: Recent Developments
Table 9.14 Marine Polymer Technologies, Inc.: Company Overview
Table 9.15 Sea Run Holdings, Inc.: Company Overview
Table 9.16 Sea Run Holdings, Inc.: Product Portfolio
Table 9.17 Aphios Corporation: Company Overview
Table 9.18 Aphios Corporation: Product Portfolio
Table 9.19 Sanofi S.A.: Company Overview
Table 9.20 Sanofi S.A.: Product Portfolio
Table 9.21 Other Companies of Interest in the Marine Derived Drugs Market
Table 9.21 Other Companies of Interest in the Marine Derived Drugs Market (continued)

Companies Listed

Abbott Laboratories
AbbVie, Inc.
Alkermes Plc
Amarin Corp. Plc
Amgen, Inc.
Amnis Corporation
Aphios Corporation
Array BioPharma, Inc.
Associates Of Cape Cod Inc.
Astex Pharmaceuticals Inc.
AstraZeneca Plc
ASYMPTOTE LTD
Bayer AG
Bayer Corporation
Bayer HealthCare AG
Bayer Schering Pharma Aktiengesellschaft
BioMarin Pharmaceutical, Inc.
Biotest AG
Bristol-Myers Squibb Co.
Cardax, Inc.
Ceapro, Inc.
Celgene Corp.
Centene Corp.
Cephalon, Inc.
Chugai Pharmaceutical Co., Ltd.
CK Life Sciences International (Holdings), Inc.
CTI BioPharma Corp.
Deroyal Industries Inc.
Domain Therapeutics SA
Emd Millipore Corporation
Emd Serono Inc.
Endo International Plc
Evotec AG
GE HEALTHCARE LTD
GlaxoSmithKline Plc
Henry Schein, Inc.
International Medical Corps
Janssen Biotech, Inc.
JHL Biotech, Inc.
Johnson & Johnson
Laboratoire Theramex
Lombard Medical, Inc.
Lonza Group AG
Marine Polymer Technology
Medtronic Plc
Merck KGaA
MorphoSys AG
Myrexis, Inc.
NBTY, Inc.
Neptune Technologies & Bioresources, Inc.
Nexvet Biopharma PLC
Nordion Inc
Novartis AG
Opexa Therapeutics, Inc.
Otsuka Pharmaceutical Co. Ltd.
Panacos Pharmaceuticals, Inc.
PELICAN HEALTHCARE LTD
Pfizer Inc.
Pharma Mar SA
Polymer Technology Systems Inc.
Premier Healthcare Alliance L.P.
Progyny Inc.
Quanterix Corp.
Samsung BioLogics Co., Ltd.
Sangers (Northern Ireland) Limited
Sanofi
Sea Run Holdings
Spectrum Pharmaceuticals, Inc.
T G EAKIN LTD
Taiho Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co., Ltd.
UnitedHealth Group, Inc.
Verastem, Inc.
Vertex Pharmaceuticals, Inc.
VWR International, LLC
Windtree Therapeutics, Inc.
Zogenix, Inc.

List of Organizations
Australian Institute Of Health And Welfare
European Medicines Agency
Food Drug and Administration
Health Canada
Ministry of Health, Labor and Welfare
National Cancer Institute
The American Society Of Clinical Oncology Inc
The Feinstein Institute For Medical Research
United States Department Of Health & Human Services
World Health Organization

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close